View in EDS

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.

Saved in:
Bibliographic Details
Title: Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Authors: Parsons DW; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Patton DR; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Winter CL; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Coffey B; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Roy-Chowdhuri S; University of Texas MD Anderson Cancer Center, Houston, TX., Tsongalis GJ; Geisel School of Medicine at Dartmouth, Hanover, NH.; Dartmouth Hitchcock Medical Center, Lebanon, NH., Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX., Ramirez NC; Biopathology Center, Research Institute at Nationwide Children's Hospital, Columbus, OH., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA., Piao J; Keck School of Medicine, University of Southern California, Los Angeles, CA., Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA., Berg SL; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX., Fox E; St Jude Children's Research Hospital, Memphis, TN., Hawkins DS; Seattle Children's Hospital and University of Washington, Seattle, WA., Abrams JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Mooney M; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD., Seibel NL; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
Corporate Authors: NCI-COG Pediatric MATCH Team
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jul 10; Vol. 40 (20), pp. 2224-2234. Date of Electronic Publication: 2022 Mar 30.
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35353553
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Parsons+DW%22">Parsons DW</searchLink>; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Janeway+KA%22">Janeway KA</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Patton+DR%22">Patton DR</searchLink>; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Winter+CL%22">Winter CL</searchLink>; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Coffey+B%22">Coffey B</searchLink>; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Williams+PM%22">Williams PM</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, MD.<br /><searchLink fieldCode="AU" term="%22Roy-Chowdhuri+S%22">Roy-Chowdhuri S</searchLink>; University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Tsongalis+GJ%22">Tsongalis GJ</searchLink>; Geisel School of Medicine at Dartmouth, Hanover, NH.; Dartmouth Hitchcock Medical Center, Lebanon, NH.<br /><searchLink fieldCode="AU" term="%22Routbort+M%22">Routbort M</searchLink>; University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Ramirez+NC%22">Ramirez NC</searchLink>; Biopathology Center, Research Institute at Nationwide Children's Hospital, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Saguilig+L%22">Saguilig L</searchLink>; Children's Oncology Group Statistical Center, Monrovia, CA.<br /><searchLink fieldCode="AU" term="%22Piao+J%22">Piao J</searchLink>; Keck School of Medicine, University of Southern California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Alonzo+TA%22">Alonzo TA</searchLink>; Keck School of Medicine, University of Southern California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Berg+SL%22">Berg SL</searchLink>; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Fox+E%22">Fox E</searchLink>; St Jude Children's Research Hospital, Memphis, TN.<br /><searchLink fieldCode="AU" term="%22Hawkins+DS%22">Hawkins DS</searchLink>; Seattle Children's Hospital and University of Washington, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Abrams+JS%22">Abrams JS</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Mooney+M%22">Mooney M</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Takebe+N%22">Takebe N</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Tricoli+JV%22">Tricoli JV</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Seibel+NL%22">Seibel NL</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22NCI-COG+Pediatric+MATCH+Team%22">NCI-COG Pediatric MATCH Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2022 Jul 10; Vol. 40 (20), pp. 2224-2234. <i>Date of Electronic Publication: </i>2022 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35353553
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.21.02838
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2224
    Titles:
      – TitleFull: Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parsons DW
      – PersonEntity:
          Name:
            NameFull: Janeway KA
      – PersonEntity:
          Name:
            NameFull: Patton DR
      – PersonEntity:
          Name:
            NameFull: Winter CL
      – PersonEntity:
          Name:
            NameFull: Coffey B
      – PersonEntity:
          Name:
            NameFull: Williams PM
      – PersonEntity:
          Name:
            NameFull: Roy-Chowdhuri S
      – PersonEntity:
          Name:
            NameFull: Tsongalis GJ
      – PersonEntity:
          Name:
            NameFull: Routbort M
      – PersonEntity:
          Name:
            NameFull: Ramirez NC
      – PersonEntity:
          Name:
            NameFull: Saguilig L
      – PersonEntity:
          Name:
            NameFull: Piao J
      – PersonEntity:
          Name:
            NameFull: Alonzo TA
      – PersonEntity:
          Name:
            NameFull: Berg SL
      – PersonEntity:
          Name:
            NameFull: Fox E
      – PersonEntity:
          Name:
            NameFull: Hawkins DS
      – PersonEntity:
          Name:
            NameFull: Abrams JS
      – PersonEntity:
          Name:
            NameFull: Mooney M
      – PersonEntity:
          Name:
            NameFull: Takebe N
      – PersonEntity:
          Name:
            NameFull: Tricoli JV
      – PersonEntity:
          Name:
            NameFull: Seibel NL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 07
              Text: 2022 Jul 10
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 20
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1